EAACI Congress 2025
BackTPS32 - Allergen immunotherapy 03
Saturday 14 Jun, 12:00 PM -
13:00 PM Glasgow, United Kingdom
Poster Zone
Thematic Poster Session
Allergenicity and Immunogenicity of Polypeptide-Conjugated Hepatitis B Core Antigen Virus‐Like-Particle (HBcAg-VLP) Vaccine for Treatment of Shellfish Allergy
EFFECTIVENESS AND SAFETY OF SPECIFIC SUBLINGUAL IMMUNOTHERAPY WITH Pru p3 EXTRACT IN PATIENTS WITH LTP ALLERGY
Effectiveness and safety of Venom ImmunoTherapy (VIT) with “Rapid Cluster” induction protocol
Epitope Analysis and Mutation Design in Jug r 1 for Hypoallergenic Walnut Immunotherapy
Factors associated with higher serum IgG4 response in children treated with allergen immunotherapy
Low dose oral immunotherapy for children with severe cow's milk allergy
Machine Learning-Based Prediction of Desensitization Success in Oral Immunotherapy for Hen’s Egg Allergy in Children
Peanut allergen-loaded microneedle array patch modulates the immune response to peanut allergy in Balb/c and C3H/HeJ mouse model
Pediatric bee venom allergy: family background matters
Randomized Controlled Trial of Sublingual Immunotherapy for Egg Allergy
Real-World Protective Effects of Epicutaneous Immunotherapy in Peanut-allergic Toddlers
Real-life observational study on the effectiveness of a broad-spectrum allergen product in unresponsive pediatric patients
Safety Profile and Clinical Outcome of Sublingual Immunotherapy (SLIT) with Pru p 3 in Patients with LTP Allergy Undergoing Food Reintroduction
Safety and efficacy of a 7-week immunotherapy protocol with aluminum hydroxide adsorbed bee venom
Study design for A multicenter, open label, randomized Study to inveStigate the effIcacy of Subcutaneous immunoTherapy combined with vitamin D3 in children and adolescent patients with allergic rhinitis (ASSIST study)
Study design for the effect of SCIT on tic symptoms in Children and Adolescents with HDM aLlergy and coMorbid tic disorders: a multicenter prospective observational study (CALM study)
Study on the Effect of the Mucosal Vaccine MV130 on Innate Immunity Factors in School-Age Children
